摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-5-<(3,5-di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)amino>-4H-imidazol-4-one | 175980-62-8

中文名称
——
中文别名
——
英文名称
2-amino-5-<(3,5-di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)amino>-4H-imidazol-4-one
英文别名
[(2R,3S,5R)-3-acetyloxy-5-[(2-amino-5-oxo-1H-imidazol-4-ylidene)amino]oxolan-2-yl]methyl acetate
2-amino-5-<(3,5-di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)amino>-4H-imidazol-4-one化学式
CAS
175980-62-8
化学式
C12H16N4O6
mdl
——
分子量
312.282
InChiKey
PKLVFPOLXMTURQ-DJLDLDEBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.1
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    142
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-amino-5-<(3,5-di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)amino>-4H-imidazol-4-one 作用下, 反应 24.0h, 以31.8 mg的产率得到2,2-diamino-4-<(3,5-di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)amino>-5-(2H)-oxazolone
    参考文献:
    名称:
    Raoul, Sebastien; Berger, Maurice; Buchko, Garry W., Journal of the Chemical Society. Perkin transactions II, 1996, # 3, p. 371 - 382
    摘要:
    DOI:
  • 作为产物:
    描述:
    3',5'-di-O-acetyl-2'-deoxyguanosine二苯甲酮 作用下, 以 为溶剂, 反应 12.0h, 以13%的产率得到2-amino-5-<(3,5-di-O-acetyl-2-deoxy-β-D-erythro-pentofuranosyl)amino>-4H-imidazol-4-one
    参考文献:
    名称:
    Raoul, Sebastien; Berger, Maurice; Buchko, Garry W., Journal of the Chemical Society. Perkin transactions II, 1996, # 3, p. 371 - 382
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Discovery and Mutagenicity of a Guanidinoformimine Lesion as a new Intermediate of the Oxidative Deoxyguanosine Degradation Pathway
    作者:Dimitrios Stathis、Ulrike Lischke、Sandra C. Koch、Christian A. Deiml、Thomas Carell
    DOI:10.1021/ja211435d
    日期:2012.3.14
    Oxidative degradation of DNA is a major mutagenic process. Reactive oxygen species (ROS) produced in the course of oxidative phosphorylation or by exogenous factors are known to attack preferentially deoxyguanosine. The latter decomposes to give mutagenic lesions, which under physiological conditions are efficiently repaired by specialized maintenance systems in the cell. Although many intermediates of the degradation pathway are today well-known, we report in this study the discovery of a new intermediate with an interesting guanidinoformimine structure. The structure elucidation of the new lesion was possible by using HPLC-MS techniques and organic synthesis. Finally we report the mutagenic potential of the new lesion in comparison to the known lesions imidazolone and oxazolone using primer extension and pyrosequencing experiments.
  • Reaction of 3′,5′-di-O-acetyl-2′-deoxyguansoine with hypobromous acid
    作者:Toshinori Suzuki、Asuka Nakamura、Michiyo Inukai
    DOI:10.1016/j.bmc.2013.04.060
    日期:2013.7
    Hypobromous acid (HOBr) is formed by eosinophil peroxidase and myeloperoxidase in the presence of H2O2, Cl-, and Br- in the host defense system of humans, protecting against invading bacteria. However, the formed HOBr may cause damage to DNA and its components in the host. When a guanine nucleoside (3',5'-di-O-acetyl-2'-deoxyguansoine) was treated with HOBr at pH 7.4, spiroiminodihydantoin, guanidinohydantoin/iminoallantoin, dehydro-iminoallantoin, diimino-imidazole, amino-imidazolone, and diamino-oxazolone nucleosides were generated in addition to an 8-bromoguanine nucleoside. The major products were spiroiminodihydantoin under neutral conditions and guanidinohydantoin/iminoallantoin under mildly acidic conditions. All the products were formed in the reaction with HOCl in the presence of Br-. These products were also produced by eosinophil peroxidase or myeloperoxidase in the presence of H2O2, Cl-, and B-. The results suggest that the products other than 8-bromoguanine may also have importance for mutagenesis by the reaction of HOBr with guanine residues in nucleotides and DNA. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
  • Identification of Products Formed by Reaction of 3‘,5‘-Di-<i>O</i>-acetyl-2‘-deoxyguanosine with Hypochlorous Acid or a Myeloperoxidase−H<sub>2</sub>O<sub>2</sub>−Cl<sup>-</sup> System
    作者:Toshinori Suzuki、Marlin D. Friesen、Hiroshi Ohshima
    DOI:10.1021/tx025638y
    日期:2003.3.1
    Hypochlorous acid (HOCl), generated by myeloperoxidase from H2O2 and Cl-, plays an important role in host defense and inflammatory tissue injury. We have studied the reaction of 3',5'-di-O-acetyl-2'-deoxyguanosine with reagent HOCl and with a human myeloperoxidase H2O2-Cl- system in order to characterize polar reaction products. When 100 muM 3',5'-di-O-acetyl-2'-deoxyguanosine was reacted with 100 muM HOCl at pH 7.4 and 37 degreesC and the reaction was terminated by N-acetylcysteine, 3',5'-di-O-acetyl derivatives of previously reported products, such as diastereomers of spiroiminodihydantoin nucleoside, a diimino-imidazole nucleoside, an amino-imidazolone nucleoside, and 8-chloro-2'-deoxyguanosine were formed. In addition, we report the formation of 3',5'-di-O-acetyl derivatives of a guanidinohydantoin nucleoside, an iminoallantoin nucleoside, and a diamino-oxazolone nucleoside in this system. The identification of the products was based on their identical ESI-MS and UV spectra and HPLC retention times with authentic compounds synthesized with other oxidation systems. All of these products were also formed in the reaction of 3',5'-di-O-acetyl-2'-deoxyguanosine with the myeloperoxidase-H2O2-Cl- system under mildly acidic conditions. The yields of the products were greatly affected by the pH of the reaction mixture. The total yields of these products formed by HOCl at pH 7.4 and by the myeloperoxidase-H2O2-Cl- system at pH 4.5 were 72 and 43% of the consumed 3',5'-di-O-acetyl-2'-deoxyguanosine, respectively, indicating that nearly half of the consumption of 3',5'-di-O-acetyl-2'-deoxyguanosine by HOCl and the myeloperoxidase-H2O2-Cl- system can be accounted for by the formation of these products.
  • Cadet; Berger; Buchko, Journal of the American Chemical Society, 1994, vol. 116, # 16, p. 7403 - 7404
    作者:Cadet、Berger、Buchko、Joshi、Raoul、Ravanat
    DOI:——
    日期:——
查看更多

同类化合物

(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2 -(羟甲基)四氢呋喃-3-醇 鲁索替尼 鲁索利尼杂质C 酸蓝129:1 迪高替尼 诺那吡胺 螺[4.4]壬烷-1-酮,6-氨基-,(5S,6S)- 苯酚,2,4-二氯-5-肼-,单盐酸 苯并呋喃,2,3-二氢-3-(1-甲基乙基)- 芦可替尼杂质5 芦可替尼杂质3 芦可替尼杂质2 聚(氧代-1,2-乙二基),a-甲基-w-[[3,4,4,4-四氟-2-[1,2,2,2-四氟-1-(三氟甲基)乙基]-1,3-二(三氟甲基)-1-丁烯-1-基]氧代]- 维贝格龙 磷酸鲁索替尼 甲基7-(2-甲氧基乙基)-1,3-二甲基-2,4-二羰基-2,3,4,7-四氢-1H-吡咯并[2,3-D]嘧啶-6-羧酸酯 甲基6,7-二氢-5H-吡咯并[3,4-D]嘧啶-2-甲酸基酯 氰基酰胺,(1-甲基-2-吡咯烷亚基)-(9CI) 杂质TFTB 替诺福韦杂质113 托法替布杂质ZJT2-I 托法替尼杂质28 托法替尼杂质2 托伐替尼杂质T 异丙基2-氨基-4-甲氧基-7h-吡咯并[2,3-d]嘧啶-6-羧酸 巴里替尼杂质5 巴瑞替尼杂质9 巴瑞替尼 巴瑞克替尼杂质 巴瑞克替尼中间体3 巴瑞克替尼中间体1 外消旋鲁替替尼-d8 培美酸 培美曲塞杂质 吡啶,1-[(2,5-二甲基苯基)甲基]-1,2,3,6-四氢- 吡咯并[1,2-a]嘧啶-3-羧酸 吡咯并[1,2-F]嘧啶-3-甲酸乙酯 吡咯并[1,2-C]嘧啶-4-腈 吡咯并[1,2-A]嘧啶-6-羧酸 吡咯并[1,2-A]嘧啶-6-甲醛 叔丁基2-氨基-4-氯-5H-吡咯并[3,4-D]嘧啶-6(7H)-羧酸酯 叔丁基-4-氯-2-吗啉代-7H-吡咯并[2,3-D]嘧啶-7-甲酸甲酯 十二烷-1,12-二基二(苯甲基二甲基铵)二氯化 化合物PFE-360 亚乙基,2-氨基-1-(乙酯基<乙氧羰基>)-2-(甲酰基亚氨基)-,(2Z)-(9CI) 二环[2.2.1]庚-5-烯-2-羧酸,丁基酯,(1R,2R,4R)- [4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 [3-(4-氨基-7H-吡咯并[2,3-d]嘧啶-7-基)环戊基]甲醇 [1-(乙基磺酰基)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]氮杂环丁烷-3-基]乙腈磷酸盐 S-鲁索替尼